US Patent Issued to BioNTech, TRON - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz gemeinnutzige on July 14 for "Compositions comprising non-immunogenic RNA encoding immunogenic epitopes and interferon alpha" (German Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,497, issued on July 14, was assigned to BioNTech SE (Mainz, Germany) and TRON - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz gemeinnutzige GmbH (Mainz, Germany).

"Compositions comprising non-immunogenic RNA encoding immunogenic epitopes and interferon alpha" was invented by Ugur Sahin (Mainz, Germany), Lena Mareen Kranz (Mainz, Germany), Mustafa Diken (Mainz, Germany), Lina Hilscher (Dortmund, Germany) and Sebastian Kreiter (Mainz, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods and agents for antigen vaccination and inducing effective antigen-specific i...